By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists agree that the choice between SCHA and ISCB is not straightforward, with each having its own risks and benefits. The key consideration is the investor's risk tolerance and investment horizon.
Risk: Concentration risk in SCHA's top holdings and potential reversals in sector performance.
Opportunity: ISCB's profitability filter and potential benefits from infrastructure spending.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The iShares Morningstar Small-Cap ETF (NYSEMKT:ISCB) offers a higher dividend yield and heavier weighting toward industrial firms, while the Schwab U.S. Small-Cap ETF (NYSEMKT:SCHA) provides lower costs and significantly greater liquidity.
The iShares fund and the Schwab fund both target the U.S. small-cap market, providing investors with broad exposure to companies outside the S&P 500. This comparison evaluates how their differing methodologies impact sector concentrations, liquidity, and overall return profiles for long-term holders as of July 10, 2026.
| Metric | SCHA | ISCB | |---|---|---| | Issuer | Schwab | iShares | | Share price | $34.91 (as of 2026-07-10) | $74.47 (as of 2026-07-10) | | Expense ratio | 0.03% | 0.04% | | 1-yr return (as of 2026-07-10) | 34.7% | 25.0% | | Dividend yield | 1.0% | 1.3% | | Beta | 1.21 | 1.12 | | AUM | $23.3B | $282.9M |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
The Schwab fund is the more affordable option with a 0.03% expense ratio. However, income-seeking investors may prefer the higher payout of the iShares fund, which offers a 1.3% dividend yield versus 1.0% for its Schwab counterpart.
| Metric | SCHA | ISCB | |---|---|---| | Max drawdown (5 yr) | (30.8%) | (29.9%) | | Growth of $1,000 over 5 years (total return) | $1,452 | $1,383 |
ISCB is designed to mirror the market performance of a benchmark comprising U.S. small-cap stocks. Its portfolio of 1,580 holdings is primarily focused on industrials (18%), technology (16%), and financial services (16%). Its largest positions include Okta at 0.37%, Sterling Infrastructure at 0.33%, and Guardant Health at 0.32%. The fund was launched in 2004.
The iShares Morningstar Small-Cap ETF has paid $0.95 per share over the trailing 12 months. At its recent $74 share price, it works out to a 1.3% yield.
SCHA seeks to replicate the Dow Jones U.S. Small-Cap Total Stock Market Index. It holds 1,725 stocks, with significant weightings in technology (22%), healthcare (16%), and financial services (15%). Its top holdings include Sandisk at 5.79%, Lumentum Holdings at 1.27%, and Revolution Medicines at 0.76%. The fund was launched in 2009.
The Schwab U.S. Small-Cap ETF has paid $0.36 per share over the trailing 12 months. At its recent $35 share price, it works out to a 1.0% yield.
For more guidance on ETF investing, check out the full guide at this link.
The better small-cap ETF isn’t necessarily the better-performing one. Schwab has delivered marginally better returns over the last five years, but that may reflect its recent heavier allocation to technology than the Morningstar ETF.
Investors who already have tech exposure through a large index fund or individual stock holdings may benefit from Morningstar’s heavier allocation to industrials — its largest sector allocation. The reindustrialization of the U.S. economy is a megatrend that could boost this fund’s returns in the coming years.
But these are both solid small-cap ETFs. A broader investor rotation into small-cap stocks will be a tailwind for both SCHA and ISCB. Both SCHA and ISCB have outperformed the S&P 500 over the last year. Assuming that relative strength continues, the better buy is the one that provides broader diversification across sectors for an investor’s portfolio.
Before you buy stock in iShares Trust - iShares Morningstar Small-Cap ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Morningstar Small-Cap ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $396,542! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,299,961!
Now, it’s worth noting Stock Advisor’s total average return is 931% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of July 16, 2026. *
John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Guardant Health, Lumentum, Okta, and Sterling Infrastructure. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"SCHA’s apparent 5.79% single-name concentration (if accurate) contradicts the diversification narrative and raises risk not addressed by the article."
The article frames SCHA vs ISCB as a near-toss-up, highlighting SCHA’s $23B AUM, 0.03% expense ratio, 34.7% 1-yr return and heavier tech tilt (22%) against ISCB’s 1.3% yield, industrial overweight (18%) and marginally lower beta. Yet the piece glosses over concentration risk: SCHA’s top holding “Sandisk” at 5.79% is implausibly large for a 1,725-name total-market index and likely an error (possibly SanDisk legacy or misprint for another name), undermining claimed diversification. Missing context includes small-cap relative valuation (Russell 2000 forward P/E still ~18x vs historical 15x), macro sensitivity to rates and tariffs, and that both ETFs’ outperformance vs S&P 500 last year was driven by the same post-election small-cap rotation that can reverse quickly. Liquidity edge of SCHA is real but largely irrelevant for buy-and-hold investors.
If the small-cap rotation continues and tech earnings keep surprising to the upside, SCHA’s lower cost, higher tech weight and superior 5-yr growth of $1,452 vs $1,383 could widen its lead, making the industrial-diversification argument in ISCB moot.
"Liquidity and expense ratios are more critical for long-term small-cap index tracking than marginal differences in dividend yield or sector-specific thematic narratives."
The article's focus on historical returns and dividend yield ignores the massive liquidity disparity: SCHA’s $23.3B AUM vs. ISCB’s $282.9M. For institutional or high-net-worth retail investors, ISCB’s thin liquidity creates significant slippage risks during market volatility, making SCHA the only viable choice for efficient exposure. Furthermore, the 'reindustrialization' narrative for ISCB is speculative; small-cap industrials are highly sensitive to interest rate cycles and domestic capex spending. SCHA’s higher tech beta (1.21) is the primary driver of its recent 34.7% performance, but this creates a concentration risk if the current growth rotation reverses. Investors should prioritize liquidity and cost efficiency over marginal yield differences in this asset class.
If small-cap industrials benefit from a sustained manufacturing super-cycle, ISCB’s sector tilt could outperform SCHA’s tech-heavy portfolio despite the liquidity drawbacks.
"Both ETFs are functionally identical cost-wise; the 9.7% return gap is a sector bet, not a fund quality gap, and the article fails to justify why tech's 12-month dominance will continue into 2026."
This article presents a false choice between two nearly identical products. Both SCHA and ISCB are low-cost, broad small-cap exposures with trivial expense ratio differences (0.03% vs 0.04%). The real story is buried: SCHA's 34.7% one-year return versus ISCB's 25.0% stems almost entirely from sector timing—SCHA's 22% tech weighting versus ISCB's 16%. But the article then contradicts itself by suggesting ISCB's industrials tilt is a 'megatrend,' without acknowledging that small-cap tech's outperformance over the past 12 months may already be priced in. The 1.21 beta on SCHA also signals higher volatility ahead. Most critically: the article omits small-cap valuations relative to large-cap, which is essential context for 2026.
If small-cap underperformance versus large-cap persists due to rate persistence or recession fears, SCHA's tech concentration becomes a liability rather than an advantage, and the article's framing of SCHA as the 'better' fund collapses.
"A blended exposure across both funds offers better resilience to regime shifts and sector rotations than betting on a single ETF."
Today’s piece leans on SCHA’s lower cost and bigger AUM as a clear win over ISCB, but that ignores regime risk in U.S. small caps. SCHA’s tech-heavy tilt and higher beta can fuel outperformance in a hot cycle, yet amplify losses when rates stay high or growth cools. ISCB’s heavier industrial exposure could provide ballast if capex and infrastructure pick up, but the 1.3% yield may not compensate for higher volatility in a downturn. The article glosses over tracking error, concentration risk in a 1,580–1,725 holding universe, and possible sector rotations. A blended, not binary, approach to small caps might be wiser.
If the cycle remains AI/tech-driven and multiples stay supported, SCHA’s tilt could win regardless of cost. Conversely, a regime shift toward infrastructure-led growth could let ISCB outperform despite its smaller size and higher yield.
"Small-cap outperformance is regime-dependent on yields, not fund tilts."
Grok's 'Sandisk' concentration critique is valid but the real flaw is treating small-cap tech's 22% weighting as durable alpha. Nobody flagged that both ETFs' recent outperformance relied on the exact same post-election beta expansion; if 10-year yields push past 4.5% in Q3, the entire small-cap premium evaporates regardless of industrial or tech tilt.
"The fundamental divide between these ETFs is the S&P 600's profitability screen versus the Dow index's broader, loss-inclusive exposure."
Grok is right to question the 'Sandisk' anomaly, but everyone is ignoring the underlying index methodology. SCHA tracks the Dow Jones U.S. Small-Cap Total Stock Market Index, while ISCB follows the S&P SmallCap 600. The S&P 600 requires companies to be profitable to enter the index, whereas the Dow index does not. This quality filter is the real differentiator, not just sector weightings or liquidity. Investors aren't choosing between funds; they are choosing between profitability and pure beta.
"Index construction (profitability filter) may matter more than sector weights for explaining SCHA vs ISCB divergence, and SCHA's lower quality could amplify losses if rates spike."
Gemini's index methodology insight is crucial and shifts the frame entirely. If ISCB's S&P 600 profitability filter explains the 9.7% return gap better than sector timing, then SCHA's outperformance may reflect lower-quality small caps riding beta, not durable alpha. This makes SCHA riskier in a downturn than the article implies. But Gemini hasn't quantified how much of the gap this explains—need to see what % of SCHA's holdings fail the profitability screen.
"Profitability screens may lag regime shifts; quantify SCHA’s profitability-pass rate to judge durability of ISCB’s edge."
Gemini’s profitability-filter argument misses timing risk. Profitability screens can lag during regime shifts, meaning a few weeks of macro stress can reclassify winners into losers in small caps. If ISCB’s gains rely on a handful of profitable names, a spike in rates or a growth slowdown could flip the dynamic quickly, narrowing ISCB’s edge. It would help to quantify what percent of SCHA’s holdings pass the profitability screen to gauge durability.
The panelists agree that the choice between SCHA and ISCB is not straightforward, with each having its own risks and benefits. The key consideration is the investor's risk tolerance and investment horizon.
ISCB's profitability filter and potential benefits from infrastructure spending.
Concentration risk in SCHA's top holdings and potential reversals in sector performance.